Vexol (Rimexolone Ophthalmic) - Summary

VEXOL SUMMARY

Vexol® 1%
(rimexolone ophthalmic suspension)

VEXOL® 1% Ophthalmic Suspension is a sterile, multi-dose topical ophthalmic suspension containing the corticosteroid, rimexolone.

VEXOL® 1% (rimexolone ophthalmic suspension) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis.

See all Vexol indications & dosage >>

VEXOL NEWS HIGHLIGHTS

Published Studies Related to Vexol (Rimexolone Ophthalmic)

[Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis] [2005.09]

Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]

Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2008.08]

Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2007.08.31]

Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion. [2006.09]

more >>

Clinical Trials Related to Vexol (Rimexolone Ophthalmic)

Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye [Completed]

more >>